BASTA JAMES
Insider CIK 1792726 · KURA Chief Legal Officer · NTLA EVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-03-02 | 2026-03-03 | 1,211 | $13.78 | $16.7K | 156,794 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-03-01 | 2026-03-03 | 65,829 | — | $0 | 65,829 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-03-01 | 2026-03-03 | 46,080 | — | $0 | 158,005 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-01-05 | 2026-01-07 | 10,397 | $9.21 | $95.8K | 101,528 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-03-04 | 2025-03-04 | 2,572 | $8.99 | $23.1K | 111,925 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-03-01 | 2025-03-04 | 57,143 | — | $0 | 57,143 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-03-01 | 2025-03-04 | 40,000 | — | $0 | 114,497 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-01-03 | 2025-01-07 | 7,074 | $12.18 | $86.2K | 74,497 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-03-04 | 2024-03-05 | 2,297 | $32.99 | $75.8K | 81,571 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-03-01 | 2024-03-05 | 46,752 | — | $0 | 46,752 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-03-01 | 2024-03-05 | 32,394 | — | $0 | 83,868 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-01-03 | 2024-01-05 | 3,805 | $29.46 | $112.1K | 51,474 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-03-02 | 2023-03-03 | 1,088 | $43.88 | $47.7K | 55,279 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-03-01 | 2023-03-03 | 34,674 | — | $0 | 34,674 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 24,539 | — | $0 | 44,098 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 12,269 | — | $0 | 56,367 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-01-04 | 2023-01-06 | 1,138 | $37.21 | $42.3K | 19,559 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 9,648 | — | $0 | 9,648 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-04 | 14,109 | — | $0 | 14,109 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-03-01 | 2022-03-03 | 9,648 | — | $0 | 20,697 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-03-01 | 2022-03-03 | 11,049 | — | $0 | 11,049 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-07-01 | 2021-07-06 | 130,000 | — | $0 | 130,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2020-03-12 | 2020-03-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-11-04 | 2019-11-05 | 175,000 | — | $0 | 175,000 | SEC↗ |